Ann Dermatol

1. MIN JH, Jo YW, Her Y, Kwon JW, et al
   Gut-Skin Axis Revisited: A Nationwide Cohort Study on the Bi-directional Relationship Between Rosacea and Irritable Bowel Syndrome.
   Ann Dermatol. 2026;38:388-396.
   

   >> Share

   
   

   
   Arab J Gastroenterol

2. ATEF M, Abdalaziz RA, Badry A, Darweesh H, et al
   The diagnostic utility of abdominal and bowel ultrasound in detecting gastrointestinal and hepatic manifestations of rheumatoid arthritis.
   Arab J Gastroenterol. 2026 Oct 5:S1687-1979(26)00116.
   

   >> Share

   
   

   
   Clin Gastroenterol Hepatol

3. ROUTHIAUX K, Van den Houte K, Balsiger L, Raymenants K, et al
   Avoidant/restrictive food intake across the gastrointestinal tract.
   Clin Gastroenterol Hepatol. 2026 Oct 9:S1542-3565(26)00743.
   

   >> Share

   
   
4. BOSMAN M, Vork L, Van Den Houte M, van Oudenhove L, et al
   Real-time abdominal pain - daily life trigger associations in IBS: a multicenter Experience Sampling Method Study.
   Clin Gastroenterol Hepatol. 2026 Oct 6:S1542-3565(26)00747.
   

   >> Share

   
   

   
   Eur J Nutr

5. REZAZADEGAN M, Saneei P, Soheilipour M, Rezazadegan N, et al
   Co-supplementation of zinc and probiotic on oxidative stress markers and sleep quality index in irritable bowel syndrome patients: a double-blind randomized controlled trial.
   Eur J Nutr. 2026;65:273.
   

   >> Share

   
   

   
   Front Gastroenterol (Lausanne)

6. MONTGOMERY S, Saraga A, Rothschild NDV, Soliman MA, et al
   Irritable bowel syndrome-like symptoms are associated with increased healthcare utilization in patients with inflammatory bowel disease.
   Front Gastroenterol (Lausanne). 2026;5:1924176.
   

   >> Share

   
   

   
   Front Med (Lausanne)

7. RUBING W, Jinying Z, Lingzu K, Xu F, et al
   Visualization analysis of research hotspots and trends in traditional Chinese medicine external therapies for irritable bowel syndrome.
   Front Med (Lausanne). 2026;13:1954763.
   

   >> Share

   
   

   
   Front Pharmacol

8. TIAN L, Bai Y, Wang S, Wang C, et al
   Codonopsis pilosula inulin-type fructan CPA ameliorates diarrhea-predominant irritable bowel syndrome via regulation of ER stress-induced autophagy and modulation of gut microbiota.
   Front Pharmacol. 2026;17:1715972.
   

   >> Share

   
   

   
   Gastro Hep Adv

9. STALLER K, Clukey J, Madva EN, Healy BC, et al
   CYP2D6 Metabolizer Status Does Not Predict Response or Tolerability of Low-Dose Nortriptyline for Irritable Bowel Syndrome With Diarrhea.
   Gastro Hep Adv. 2026;5:101111.
   

   >> Share

   
   

   
   Intern Emerg Med

10. HOD K, Marasco G, Colecchia L, Sperber AD, et al
    Life-course hygiene exposures and disorders of gut-brain interaction: a multinational cross-sectional study.
    Intern Emerg Med. 2026 Oct 8. doi: 10.1007/s11739-026-04546.
    

    >> Share

    
    

    
    J Breath Res

11. VAN VORSTENBOSCH R, Esenkova EE, Jonkers DMAE, Elizalde Vilalta M, et al
    Investigating the presence of microbiota-based phenotypes in Irritable Bowel Syndrome.
    J Breath Res. 2026 Oct 5. doi: 10.1088/1752-7163.
    

    >> Share

    
    

    
    J Cancer Surviv

12. LI W, Zhang Z, Lu C, Xu Y, et al
    Frailty and risk of common chronic diseases among cancer survivors: a prospective cohort study.
    J Cancer Surviv. 2026 Oct 9. doi: 10.1007/s11764-026-02118.
    

    >> Share

    
    

    
    J Korean Med Sci

13. HASANUZZAMAN M, Bang CS, Lee JJ, Gong EJ, et al
    Fecal Microbiota Transplantation Beyond Clostridioides difficile Infection: Expanding Indications, Mechanisms, and Future Directions.
    J Korean Med Sci. 2026;41:e335.
    

    >> Share

    
    

    
    J Med Microbiol

14. GUADANO-PROCESI I, Garcia Ramos A, Gentekaki E, Tsaousis AD, et al
    Exploring Blastocystis: hidden complexity in a common intestinal microbe.
    J Med Microbiol. 2026;75:002198.
    

    >> Share

    
    

    
    J Microbiol Biotechnol

15. LIMAYE S, Bhide P, Kale A, Bokey N, et al
    SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India.
    J Microbiol Biotechnol. 2026;36:e2605029.
    

    >> Share

    
    

    
    J Psychosom Res

16. RAMISCH M, Benz-Sahnoun S, Guenther V, Korn A, et al
    Personalized psychotherapy in irritable bowel syndrome: results from a pilot randomized controlled trial (PIONEER-IBS).
    J Psychosom Res. 2026;211:113003.
    

    >> Share

    
    

    
    Lancet Gastroenterol Hepatol

17. NG DYL, Biesiekierski J, Hebbard G, Talley NJ, et al
    Validation of Rome V for irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2026;11:953-954.
    

    >> Share

    
    
18. SIMREN M, Aziz I, Tack J
    Validation of Rome V for irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2026;11:954-955.
    

    >> Share

    
    
19. STALLER K, Goodoory VC, Khasawneh M, Black CJ, et al
    Validation of Rome V for irritable bowel syndrome - Authors' reply.
    Lancet Gastroenterol Hepatol. 2026;11:955-956.
    

    >> Share

    
    

    
    Med Sci Monit

20. PAN L, Ran P, Jiang F, Wang Y, et al
    Role of Bile Acid Receptors in Non-Infectious Diarrhea: A Narrative Review.
    Med Sci Monit. 2026;32:e952723.
    

    >> Share

    
    

    
    Naunyn Schmiedebergs Arch Pharmacol

21. TALEBI SS, Ahmadimoghaddam D, Mirjalili M, Keshavarzi A, et al
    Agomelatine improves symptom severity and quality of life in diarrhea-predominant irritable bowel syndrome: insights from a randomized controlled clinical trial.
    Naunyn Schmiedebergs Arch Pharmacol. 2026 Oct 8. doi: 10.1007/s00210-026-05975.
    

    >> Share

    
    

    
    Probiotics Antimicrob Proteins

22. KIM JH, Park SJ, Huh CS, Shin CH, et al
    Lactiplantibacillus Plantarum CKDB008 and Lacticaseibacillus Rhamnosus LDTM7511 Attenuate Visceral Hypersensitivity and Suppress Serum IgE in an Acetic Acid-Induced IBS-Like Rat Model.
    Probiotics Antimicrob Proteins. 2026 Oct 9. doi: 10.1007/s12602-026-11238.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share